ArticleSignal transduction and targeted therapy2024

Efficacy and safety of human umbilical cord-derived mesenchymal stem cells in the treatment of refractory immune thrombocytopenia: a prospective, single arm, phase I trial.

Yunfei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.